HFA Premium Access

Late breaking trial IV - Registries

Event: Heart Failure 2018 & World Congress on Acute Heart Failure
Topic: Chronic Heart Failure, Other
Session type: Special Session
Date: 28 May 2018
Time: 16:30 - 18:00

Session

12 presentations in this session

Association between sacubitril/valsartan initiation and health status outcomes in heart failure with reduced ejection fraction: findings from the CHAMP-HF registry

Speaker: Doctor Y. Khariton (Kansas City, US)
Thumbnail

Discussion - Sacubitril/Valsartan initiation and health status outcomes in HFrEF

Thumbnail

Subtle ventricular dysfunction outperforms other risk markers in patients with coronary artery disease

Speaker: Professor D. Kotecha (Birmingham, GB)
Thumbnail

Discussion - ARM-CAD

Thumbnail

Rivaroxaban plus aspirin in patients with and without heart failure and chronic coronary or peripheral artery disease: the COMPASS trial

Speaker: Professor K. Branch (Seattle, US)
Thumbnail

Discussion - COMPASS CHF

Thumbnail

Essential care following incident heart failure: a population-based study of diagnostic tests, drug prescriptions and follow-up patterns in 93,000 patients

Speaker: Doctor N. Conrad (Leuven, BE)
Thumbnail

Discussion - Essential care following incident heart failure

Thumbnail

Heart failure with preserved, mid-range and reduced ejection fraction in non-Western countries

Speaker: Doctor H. Dokainish (Hamilton, CA)
Thumbnail

Discussion - INTER-CHF

Thumbnail

6 speakers from this session

Doctor Yevgeniy Khariton

St. Luke's Mid America Heart Institute, Kansas City (United States of America)
1 presentation
0 follower

Professor Dipak Kotecha

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)
26 presentations
0 follower

Professor Kelley Branch

University of Washington, Seattle (United States of America)
4 presentations
0 follower

Doctor Nathalie Conrad

University of Leuven, Leuven (Belgium)
2 presentations
0 follower

Doctor Hisham Dokainish

McMaster University, Hamilton (Canada)
7 presentations
1 follower

Professor Mitja Lainscak

General Hospital Murska Sobota, Murska Sobota (Slovenia)
27 presentations
0 follower

This platform is supported by

logo Novo Nordisk